Key facts
- This page summarizes Stefano Buono's Form 3 filing for newcleo plc (NWCL).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 21 Sep 2026, 21:12.
Stefano Buono - 21 Sep 2026 Form 3 Insider Report for newcleo plc (NWCL)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- NWCL
- Reported as of
- 21 Sep 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Kateryna Fedorova, attorney-in-fact for Stefano Buono
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Stefano Buono filed Form 3 for newcleo plc (NWCL) on 21 Sep 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001665113
Primary reporting owner
Buono Stefano
- Relationship
- Chief Executive Officer, Director
- Address
- 55 SOUTH AUDLEY STREET, LONDON, UNITED KINGDOM
- Signature
- /s/ Kateryna Fedorova, attorney-in-fact for Stefano Buono
- Signature date
- 21 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NWCL
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 119,603
- Date
- 21 Sep 2026
- Ownership
- Direct
NWCL
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 19,210,290
- Date
- 21 Sep 2026
- Ownership
- See Footnote
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NWCL
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 21 Sep 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 1,345,960
- Exercise price
- $0.0228
- Footnotes
- F2
NWCL
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 21 Sep 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 42,919
- Exercise price
- $0.0228
- Footnotes
- F3
NWCL
holding
Derivative
Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 21 Sep 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 98,143
- Exercise price
- $0.0228
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents Ordinary Shares held by Elysia Capital I SCSp. The Reporting Person is the beneficial owner of the Ordinary Shares held by Elysia Capital I SCSp and has sole voting and dispositive power of the Ordinary Shares held by such entity.
Footnote F2
Represents stock options granted on December 1, 2025 that are subject to time-based vesting that vest 25% on each of the first four anniversaries of the grant date, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
Footnote F3
Represents stock options granted on September 1, 2023 that are subject to time-based vesting that vest 25% on each of the first four anniversaries of the grant date, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
Footnote F4
Represents stock options granted on September 1, 2022 that are subject to time-based vesting that vest 25% on each of the first four anniversaries of the grant date, subject to continued employment on each vesting date and applicable accelerated vesting provisions.
SEC remarks
Exhibit List: Exhibit 24 - Power of Attorney